Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Par Pharmaceutical Companies | Headlines

  • Vol:
  • Last Trade:
Search found 27 documents NextNext
1: Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
PR NEWSWIRE, February 5, 2010 04:45 PM

2: Par Pharmaceutical to Host Analyst Day on December 3rd
PR NEWSWIRE, November 16, 2009 04:15 PM

3: Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER
PR NEWSWIRE, November 16, 2009 08:00 AM

4: Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
PR NEWSWIRE, November 9, 2009 05:45 PM

5: Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009
PR NEWSWIRE, November 6, 2009 07:30 AM

6: Par Pharmaceutical to Host Third Quarter 2009 Earnings Conference Call On November 6 at 9:00 am
PR NEWSWIRE, October 22, 2009 09:00 AM

7: Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
PR NEWSWIRE, October 14, 2009 05:09 PM

8: FDA Accepts Drug Application for Miconazole Lauriad(R) to Treat Oropharyngeal Candidiasis
PR NEWSWIRE, August 19, 2009 08:00 AM

9: Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
PR NEWSWIRE, August 18, 2009 06:37 PM

10: Par Pharmaceutical Wins on Invalidity in Ultram(R) ER Litigation
PR NEWSWIRE, August 17, 2009 08:00 AM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top